单位:[1]Tianjin Key Laboratory of Tumor Microenvironment and Neurovascular Regulation, Medical College of Nankai University, Tianjin 300071, China.[2]Department of Internal Medicine, Wangdingdi Hospital, Tianjin 300071, China.[3]Liver Transplant Center of Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China.临床科室国家中心普外分中心普外四科(肝脏移植外科)首都医科大学附属北京友谊医院[4]Institute of Clinical Medicine, Jiangxi Provincial People's Hospital Affiliated to Nanchang University, Nanchang 330006, Jiangxi Province, China.[5]Organ Transplantation Center, Affiliated Hospital of Qingdao University, Qingdao 266000, Shandong Province, China.[6]Institute of Transplantation Medicine, Tianjin First Central Hospital, Nankai University, Tianjin 300071, China
第一作者单位:[1]Tianjin Key Laboratory of Tumor Microenvironment and Neurovascular Regulation, Medical College of Nankai University, Tianjin 300071, China.
通讯作者:
通讯机构:[6]Institute of Transplantation Medicine, Tianjin First Central Hospital, Nankai University, Tianjin 300071, China[*1]Institute of Transplantation Medicine, Tianjin First Central Hospital, Nankai University, Tianjin 300071, China
推荐引用方式(GB/T 7714):
Wang Zhao-Yang,Liu Yu,Li Shi-Peng,et al.Hypoxia inducible factor 1α promotes interleukin-1 receptor antagonist expression during hepatic ischemia-reperfusion injury[J].World Journal Of Gastroenterology.2022,28(38):5573-5588.doi:10.3748/wjg.v28.i38.5573.
APA:
Wang Zhao-Yang,Liu Yu,Li Shi-Peng,Li Jian-Jun,Zhang Zhen...&Yang Shuang.(2022).Hypoxia inducible factor 1α promotes interleukin-1 receptor antagonist expression during hepatic ischemia-reperfusion injury.World Journal Of Gastroenterology,28,(38)
MLA:
Wang Zhao-Yang,et al."Hypoxia inducible factor 1α promotes interleukin-1 receptor antagonist expression during hepatic ischemia-reperfusion injury".World Journal Of Gastroenterology 28..38(2022):5573-5588